thalidomide

Trials studying thalidomide

• phase2A Clinical Study to Test the Effects of Ruxolitinib And Thalidomide Combination for Patients With Myelofibrosisactive not recruitingn=30
• phase2Escalating Doses of Thalidomide in Conjunction With Bortezomib and HIgh Dose Melphalan for BSCTcompletedn=29
• phase22015-12: A Study Exploring the Use of Early and Late Consolidation/Maintenance Therapyactive not recruitingn=50
• phase3Study of Dexamethasone Plus IXAZOMIB (MLN9708) or Physicians Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosisterminatedn=177
• phase1A Study of JNJ-54767414 (HuMax CD38) (Anti-CD38 Monoclonal Antibody) in Combination With Backbone Treatments for the Treatment of Patients With Multiple Myelomacompletedn=240
• phase3A Study to Evaluate Daratumumab in Transplant Eligible Participants With Previously Untreated Multiple Myelomacompletedn=1,085
• phase3Velcade (Bortezomib) Consolidation After Transplantcompletedn=256
• phase2Daratumumab-Based Therapy for the Treatment of Newly Diagnosed Multiple Myeloma With Kidney Failureterminatedn=17